The diagnostic ability for hepatic steatosis using Liver Fat Quantification in EPIC(Philips)

The diagnostic ability for hepatic steatosis using Liver Fat Quantification in EPIC(Philips) - The diagnostic ability for hepatic steatosis using Liver Fat Quantification

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053147

Enrollment

100

Registered

2023-12-20

Start date

2022-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Chronic hepatitis patients who can sign a informed consent form and express their intention to participate in the study 2. Chronic hepatitis patients who have performed MRI-PDFF or liver biopsy within 3 months of measuring LFQ 3.Chrnonic hepatitis patients performed abdominal ultrasound examination

Exclusion criteria

Exclusion criteria: 1. Chronic hepatitis patients who have difficulty understanding ultrasound examinations and research content 2. Chronic hepatitis patients who cannot lie with supine position in measuring LFQ. 3. Chronic hepatitis patients under 18 years old 4. Chronic hepatitis patinets with ascites. 5. Chronic hepatitis patients who are judged unsuitable by physician

Design outcomes

Primary

Measure	Time frame
The diagnostic ability for hepatic steatosis of LFQ using MRI-PDFF or hepatic histological evaluation as refarence stabdard	—

Countries

Japan

Contacts

Public ContactTakashi Nishimura

Hyogo Medical University Department of Gastroenterology/Ultrasound Imaging Center

tk-nishimura@hyo-med.ac.jp0798-45-6472

Outcome results